TY - JOUR KW - Antibodies, Bacterial KW - Antigens, Bacterial KW - Biopsy KW - Glycolipids KW - Humans KW - Immunoglobulin M KW - leprosy KW - Mycobacterium leprae KW - Skin AU - Teixeira AC AU - Cruvinel DL AU - Roma FR AU - Luppino LF AU - Resende LHP AU - Sousa T AU - Bührer-Sékula S AU - Goulart IMB AB -

This study examined the correlation between the clinical and laboratory diagnosis of leprosy, using biopsy results from laboratories 'A' and 'B' and the ML Flow test. Clinical and histopathological diagnoses presented 67.6% agreement. The laboratories showed 73.7% agreement in the bacterial index and laboratory 'B' detected 25.4% more positives. The highest agreement was in the LL form and lowest, in the I form. The highest diagnostic discrepancy was for the BB form. Clinical diagnosis agreement was 41.3% for laboratory 'A' and 54% for 'B'. The ML Flow test reclassified 10.7% of the patients. The spectrum of leprosy classification is important for a clearer understanding of the disease and its proper treatment, but is not used in health services, which use the simplified WHO criteria. This could be complemented by ML Flow testing. Such simplification is unacceptable for Leprosy Reference Centers regarding patient attendance, teaching and research, for which the standardization of the Ridley-Jopling classification is recommended.

BT - Revista da Sociedade Brasileira de Medicina Tropical C1 - http://www.ncbi.nlm.nih.gov/pubmed/19618076?dopt=Abstract DA - 2008 DO - 10.1590/s0037-86822008000700011 J2 - Rev. Soc. Bras. Med. Trop. LA - eng N2 -

This study examined the correlation between the clinical and laboratory diagnosis of leprosy, using biopsy results from laboratories 'A' and 'B' and the ML Flow test. Clinical and histopathological diagnoses presented 67.6% agreement. The laboratories showed 73.7% agreement in the bacterial index and laboratory 'B' detected 25.4% more positives. The highest agreement was in the LL form and lowest, in the I form. The highest diagnostic discrepancy was for the BB form. Clinical diagnosis agreement was 41.3% for laboratory 'A' and 54% for 'B'. The ML Flow test reclassified 10.7% of the patients. The spectrum of leprosy classification is important for a clearer understanding of the disease and its proper treatment, but is not used in health services, which use the simplified WHO criteria. This could be complemented by ML Flow testing. Such simplification is unacceptable for Leprosy Reference Centers regarding patient attendance, teaching and research, for which the standardization of the Ridley-Jopling classification is recommended.

PY - 2008 SP - 48 EP - 55 T2 - Revista da Sociedade Brasileira de Medicina Tropical TI - Evaluation of the agreement between clinical and laboratorial exams in the diagnosis of leprosy. VL - 41 Suppl 2 SN - 1678-9849 ER -